Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory A Grabowski

Showing results (11-20 of 128) with videos related to

Pageof 13
Sort By:
Molecular Genetics and Metabolism|December 8, 2016
Ten plus one challenges in diseases of the lysosomal systemGregory A Grabowski, Chester Whitley
Autophagy|May 12, 2010
Impaired autophagosomes and lysosomes in neuronopathic Gaucher diseaseYing Sun, Gregory A Grabowski
Current Opinion in Lipidology|September 14, 2004
Lysosomal acid lipase and atherosclerosisHong Du, Gregory A Grabowski
Molecular Genetics and Metabolism|February 17, 2009
Participation of asparagine 370 and glutamine 235 in the catalysis by acid beta-glucosidase: the enzyme deficient in Gaucher diseaseBenjamin Liou, Gregory A Grabowski
Molecular Genetics and Metabolism|January 10, 2012
Is E326K glucocerebrosidase a polymorphic or pathological variant?Benjamin Liou, Gregory A Grabowski
Molecular Genetics and Metabolism|August 7, 2022
Therapies for lysosomal storage diseases: Principles, practice, and prospects for refinements based on evolving scienceGregory A Grabowski, Pramod K Mistry
Developmental Disabilities Research Reviews|June 26, 2013
Neuronopathic lysosomal storage diseases: clinical and pathologic findingsCarlos E Prada, Gregory A Grabowski
Journal of Clinical Lipidology|September 29, 2016
Response to "Letter to the Editor by Drs Block and Razani"Gregory A Grabowski, Robert J Desnick
Annual Review of Genomics and Human Genetics|October 7, 2003
Enzyme therapy for lysosomal storage disease: principles, practice, and prospectsGregory A Grabowski, Robert J Hopkin
Clinical Investigation|September 20, 2011
Velaglucerase alfa in the treatment of Gaucher disease type 1Thomas A Burrow, Gregory A Grabowski
Pageof 13

Showing results (11-20 of 128) with videos related to

Sort By:
Pageof 13
Molecular Genetics and Metabolism|December 8, 2016
Ten plus one challenges in diseases of the lysosomal systemGregory A Grabowski, Chester Whitley
Autophagy|May 12, 2010
Impaired autophagosomes and lysosomes in neuronopathic Gaucher diseaseYing Sun, Gregory A Grabowski
Current Opinion in Lipidology|September 14, 2004
Lysosomal acid lipase and atherosclerosisHong Du, Gregory A Grabowski
Molecular Genetics and Metabolism|February 17, 2009
Participation of asparagine 370 and glutamine 235 in the catalysis by acid beta-glucosidase: the enzyme deficient in Gaucher diseaseBenjamin Liou, Gregory A Grabowski
Molecular Genetics and Metabolism|January 10, 2012
Is E326K glucocerebrosidase a polymorphic or pathological variant?Benjamin Liou, Gregory A Grabowski
Molecular Genetics and Metabolism|August 7, 2022
Therapies for lysosomal storage diseases: Principles, practice, and prospects for refinements based on evolving scienceGregory A Grabowski, Pramod K Mistry
Developmental Disabilities Research Reviews|June 26, 2013
Neuronopathic lysosomal storage diseases: clinical and pathologic findingsCarlos E Prada, Gregory A Grabowski
Journal of Clinical Lipidology|September 29, 2016
Response to "Letter to the Editor by Drs Block and Razani"Gregory A Grabowski, Robert J Desnick
Annual Review of Genomics and Human Genetics|October 7, 2003
Enzyme therapy for lysosomal storage disease: principles, practice, and prospectsGregory A Grabowski, Robert J Hopkin
Clinical Investigation|September 20, 2011
Velaglucerase alfa in the treatment of Gaucher disease type 1Thomas A Burrow, Gregory A Grabowski
Pageof 13